US EditionAOTI diabetic foot care therapy to be used by NHS - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
AOTI diabetic foot care therapy to be used by NHS - Pharmafile
Effective from September 2025, AOTI’s Topical Wound Oxygen (TWO2) therapy has been awarded inclusion in the NHS supply chain. It treats diabetic foot ulcer (DFU) and significantly lowers overall diabetic foot care costs. This adoption follows the publication of results from a health economic (HE) study in the Journal of Diabetic Complications that demonstrated that the […] The post AOTI diabetic foot care therapy to be used by NHS appeared first…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
